Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C

被引:71
作者
Komiya, Yutaka [1 ,2 ,3 ,4 ,5 ,6 ]
Katayama, Keiko [1 ,2 ,3 ,4 ,5 ,6 ]
Yugi, Hisao [1 ,2 ,3 ,4 ,5 ,6 ]
Mizui, Masaaki [1 ,2 ,3 ,4 ,5 ,6 ]
Matsukura, Harumichi [1 ,2 ,3 ,4 ,5 ,6 ]
Tomoguri, Tetsushi [1 ,2 ,3 ,4 ,5 ,6 ]
Miyakawa, Yuzo [1 ,2 ,3 ,4 ,5 ,6 ]
Tabuchi, Ayako [1 ,2 ,3 ,4 ,5 ,6 ]
Tanaka, Junko [1 ,2 ,3 ,4 ,5 ,6 ]
Yoshizawa, Hiroshi [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Epidemiol Infect Dis Control & Prevent, Minami Ku, Hiroshima 7348551, Japan
[2] Sanwa Kagaku Kenkyusho Ltd, Kumamoto, Japan
[3] Japanese Red Cross Soc, Cent Blood Inst, Dept NAT, Tokyo, Japan
[4] Japanese Red Cross Hiroshima Blood Ctr, Dept Lab Med, Hiroshima, Japan
[5] Japanese Red Cross Osaka Blood Ctr, Dept Res & Dev Reagents, Osaka, Japan
[6] Miyakawa Mem Res Fdn, Tokyo, Japan
关键词
WINDOW PERIOD; HBV INFECTION; DNA; BLOOD; AMPLIFICATION; ANTIGEN; SERUM; NAT; TRANSMISSION; TRANSFUSION;
D O I
10.1111/j.1537-2995.2007.01522.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: In planning optimal hepatitis B virus (HBV) blood screening strategies, the minimum infectious dose and early dynamics of HBV need to be determined for defining the window period for HBV DNA as well as for hepatitis B surface antigen (HBsAg). STUDY DESIGN AND METHODS: Pairs of chimpanzees were inoculated with preacute-phase inocula containing HBV of genotype A or genotype C to determine the minimum infectious dose, and two pairs of chimps infected with the lowest infectious dose of genotypes A and C were followed for HBV markers. RESULTS: The minimum 50 percent chimpanzee infectious dose (CID50) was estimated to be approximately 10 copies for genotype A and for genotype C. In the two chimps inoculated with the lowest infectious dose, the HBV DNA window was 55 to 76 days for genotype A and 35 to 50 days for genotype C, respectively. The HBsAg window was 69 to 97 days for genotype A and 50 to 64 days for genotype C, respectively. The doubling times of HBV DNA were 3.4 days (95% confidence interval [CI], 2.6-4.9 days) for genotype A and 1.9 days (95% CI, 1.6-2.3 days) for genotype C. When comparing the replication velocity of HBV DNA between the two genotypes, the doubling time of genotype C was significantly shorter than that of HBV genotype A (p < 0.01). CONCLUSION: Although the CID50 of approximately 10 copies was similar for the two HBV genotypes, the doubling time and pre-HBV nucleic acid amplification technology (< 100 copies/mL) window period in chimps infected with the lowest infectious dose seemed to be shorter for genotype C than for genotype A.
引用
收藏
页码:286 / 294
页数:9
相关论文
共 22 条
  • [1] RELATIONSHIP OF VIRUS DOSE TO INCUBATION TIME OF CLINICAL HEPATITIS AND TIME OF APPEARANCE OF HEPATITIS - ASSOCIATED ANTIGEN
    BARKER, LF
    MURRAY, R
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1972, 263 (01) : 27 - &
  • [2] AN ASSAY FOR THE DETECTION OF THE DNA GENOME OF HEPATITIS-B VIRUS IN SERUM
    BERNINGER, M
    HAMMER, M
    HOYER, B
    GERIN, JL
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1982, 9 (01) : 57 - 68
  • [3] Comparative sensitivity of HBVNATs and HBsAg assays for detection of acute HBV infection
    Biswas, R
    Tabor, E
    Hsia, CC
    Wright, DJ
    Laycock, ME
    Fiebig, EW
    Peddada, L
    Smith, R
    Schreiber, GB
    Epstein, JS
    Nemo, GJ
    Busch, MP
    [J]. TRANSFUSION, 2003, 43 (06) : 788 - 798
  • [4] A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors
    Busch, MP
    Glynn, SA
    Stramer, SL
    Strong, DM
    Caglioti, S
    Wright, DJ
    Pappalardo, B
    Kleinman, SH
    [J]. TRANSFUSION, 2005, 45 (02) : 254 - 264
  • [5] Quantification of hepatitis B virus genomes and infectivity in human serum samples
    Hsia, Chu Chieh
    Purcell, Robert H.
    Farshid, Mahmood
    Lachenbruch, Peter A.
    Yu, Mei-ying W.
    [J]. TRANSFUSION, 2006, 46 (10) : 1829 - 1835
  • [6] Titration of hepatitis C virus in chimpanzees for determining the copy number required for transmission
    Katayama, K
    Kumagai, J
    Komiya, Y
    Mizui, M
    Yugi, H
    Kishimoto, S
    Yamanaka, R
    Tamatsukuri, S
    Tomoguri, T
    Miyakawa, Y
    Tanaka, J
    Yoshizawa, H
    [J]. INTERVIROLOGY, 2004, 47 (01) : 57 - 64
  • [7] Assessing the impact of HBV NAT on window period reduction and residual risk
    Kleinman, Steven H.
    Busch, Michael P.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S23 - S29
  • [8] POSTTRANSFUSION FULMINANT HEPATITIS-B ASSOCIATED WITH PRECORE-DEFECTIVE HBV MUTANTS
    KOJIMA, M
    SHIMIZU, M
    TSUCHIMOCHI, T
    KOYASU, M
    TANAKA, S
    IIZUKA, H
    TANAKA, T
    OKAMOTO, H
    TSUDA, F
    MIYAKAWA, Y
    MAYUMI, M
    [J]. VOX SANGUINIS, 1991, 60 (01) : 34 - 39
  • [9] Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening
    Minegishi, K
    Yoshikawa, A
    Kishimoto, S
    Yugi, H
    Yokoya, N
    Sakurada, M
    Kiyokawa, H
    Nishioka, K
    [J]. VOX SANGUINIS, 2003, 84 (04) : 287 - 291
  • [10] NISHIOKA K, 1991, LANCET, V338, P1040